Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Stock
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2,835,071
-
Shares change
-
-3,422
-
Total reported value, excl. options
-
$32,595,000
-
Value change
-
-$36,517
-
Number of buys
-
3
-
Number of sells
-
4
-
Price
-
$11.50
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q4 2015
As of 31 Dec 2015 SUMMIT THERAPEUTICS INC COM - Stock (SMMT) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,835,071 shares of stock of the company.
Largest 10 holders included LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, SPHERA FUNDS MANAGEMENT LTD., First Eagle Investment Management, LLC, Granite Point Capital Management, L.P., EverPoint Asset Management, LLC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and LADENBURG THALMANN FINANCIAL SERVICES INC.
This table shows 10 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.